{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:38:14Z","timestamp":1774312694628,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cryoglobulinemic vasculitis (<jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>) can develop in 1.2\u20134% of hepatitis B virus (HBV)\u2010infected patients. <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> infection affects about 350 million people worldwide. It can progress from acute or fulminant hepatitis to chronic hepatitis, cirrhosis or hepatocellular carcinoma. Twenty per cent of <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> patients may develop extra\u2010hepatic manifestations, such as polyarteritis nodosa, glomerulonephritis, dermatitis, polyarthralgias and arthritis, lung disease, aplastic anaemia. Our review focuses on the role of antiviral agent nucleot(s)ide analogues (<jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>s) in treatment of <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>\u2010related <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>. The studies in literature have demonstrated that <jats:styled-content style=\"fixed-case\">NAs<\/jats:styled-content> therapy in <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>\u2010related <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content> yields high virological and satisfying clinical responses in most patients with mild\u2010and\u2010moderate <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>, but a low response in severe <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>. Overall, <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>s represent a promising therapeutic option for <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>\u2010related <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>. Obtaining early suppression of <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> viral load should be the main virological and clinical goal in order to prevent organ complications and lymphoproliferative disorders.<\/jats:p>","DOI":"10.1111\/joim.12913","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T10:26:16Z","timestamp":1558693576000},"page":"290-298","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hepatitis B virus\u2010related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review"],"prefix":"10.1111","volume":"286","author":[{"given":"C.","family":"Mazzaro","sequence":"first","affiliation":[{"name":"Clinical Experimental Onco\u2010Haematology Unit Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-200X","authenticated-orcid":false,"given":"L.","family":"Dal Maso","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Visentini","sequence":"additional","affiliation":[{"name":"Depatment of Clinical Medicine Laboratory affiliated to Istituto Pasteur Italia\u2010Fondazione Cenci Bolognetti Sapienza Unversity of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gitto","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences Center for the Study and Research of Hepatitis University of Bologna Policlinico di San Orsola Bologna Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Andreone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine University of Florence Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Toffolutti","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Unit Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gattei","sequence":"additional","affiliation":[{"name":"Clinical Experimental Onco\u2010Haematology Unit Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra031087"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92250-W"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.08.008"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.10.001"},{"key":"e_1_2_7_6_1","first-page":"115","article-title":"Cryoglobulinemias: a muloti\u2010centree study of the early clinical an laboratory manifestations of primary and secondary disease. GISCF. Italian Group for the Studyof Cryoglobulinaemias","volume":"88","author":"Monti G","year":"1995","journal-title":"QJM"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6020035"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90852-3"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206699"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60242-0"},{"issue":"2","key":"e_1_2_7_11_1","first-page":"SII20","article-title":"HCV and cryoglobulinemic vasculitis","volume":"69","author":"Ferri C","year":"2002","journal-title":"Clin J Med"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00627.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.029"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2009.03.006"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-3-287"},{"issue":"103","key":"e_1_2_7_16_1","first-page":"67","article-title":"HCV\u2010unrelated cryoglobulinemic vasculitis: the results of a prospective observational study by the Italian Group for the study of cryoglobulinemias (GISC)","volume":"35","author":"Galli M","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_17_1","first-page":"S28","article-title":"Hepatitis B virus caused mixed cryoglobulinemia by driving clonal expansion of innate B\u2010cells producing a VH1\u201069\u2010encoded antibody","volume":"34","author":"Visentini M","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.03.018"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1816"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-12-200812160-00019"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200231"},{"key":"e_1_2_7_22_1","first-page":"155","article-title":"Successful treatment of hepatitis B virus infection and related cryoglobulinemic purpura, with nucleoside\/nucleotide analogues","volume":"31","author":"D'Amico E","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.10.014"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355778"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28981"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.294"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142313"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200107000-00004"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28297"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2101"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28753"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.03.006"},{"key":"e_1_2_7_34_1","first-page":"1","article-title":"Long\u2010term effects of the new direct antiviral agents (DAAs) therapy for HCV\u2010related mixed cryoglobulinaemia: a multicentre open\u2010label study","volume":"13","author":"Mazzaro C","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890440404"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7261-7"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324652"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.78"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2012.03.033"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15053"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2856"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.01.008"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel004"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.3.391"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000183849"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12913","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/joim.12913","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:45:16Z","timestamp":1694306716000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1111\/joim.12913"],"URL":"https:\/\/doi.org\/10.1111\/joim.12913","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"assertion":[{"value":"2019-05-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}